文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛消化、代谢与肾脏急症

肝硬化对急性呼吸窘迫综合征患者结局及时间趋势的影响:一项观察性队列研究

Outcomes and time trends of acute respiratory distress syndrome patients with and without liver cirrhosis: an observational cohort.
PubMed 文献 · Ann Intensive Care · 2023-09-29
一句话结论在采用肺保护性通气的急性呼吸窘迫综合征患者中,肝硬化与90天死亡率独立相关(HR=1.56,95%CI 1.20-2.02),且两组死亡率随时间均无变化。

该研究为单中心回顾性分析前瞻性观察性队列,纳入2003年10月至2021年12月一家20张床位的三级ICU中所有连续成人急性呼吸窘迫综合征(ARDS)患者,ARDS按柏林标准定义,共863例,其中157例(18%)合并肝硬化。主要结局为90天死亡率,肝硬化组57%(90/157) vs 非肝硬化组41%(288/706)(p<0.001);多因素Cox分析显示肝硬化与90天死亡率独立相关(HR=1.56,95%CI 1.20-2.02)。两组死亡率随时间无变化;非肝硬化组SOFA(p=0.04)和非肝SOFA(p=0.02)随时间升高,肝硬化组保持稳定。两组潮气量、呼气末正压、平台压及驱动压无差异。

要点

  • 在863例ARDS患者中,18%(157例)合并肝硬化,其90天死亡率为57%(90/157),显著高于非肝硬化组的41%(288/706)(p<0.001)。
  • 多因素分析显示肝硬化是ARDS患者90天死亡率的独立危险因素(HR=1.56,95%CI 1.20-2.02)。
  • 合并与不合并肝硬化的ARDS患者90天死亡率在研究期间均无随时间变化。
  • 非肝硬化ARDS患者SOFA评分(p=0.04)和非肝SOFA评分(p=0.02)随时间升高,而肝硬化患者保持稳定。
  • 两组患者的潮气量、呼气末正压、平台压及驱动压无差异。

适用人群与场景

  • 2003年10月至2021年12月在一家20张床位的三级ICU连续纳入的所有成人危重ARDS患者。
  • ARDS按柏林标准定义。

诊断标准与关键阈值

  • ARDS诊断标准:柏林标准。

研究设计与关键结果

  • 研究类型:对前瞻性观察性队列的回顾性分析,单中心(20张床位三级ICU),时间跨度2003年10月至2021年12月。
  • 筛查7155例患者,863例诊断为ARDS,其中157例(18%)合并肝硬化。
  • 90天总死亡率为43%(378/863);肝硬化组为57%(90/157),非肝硬化组为41%(288/706)(p<0.001)。
  • 生存曲线显示肝硬化与90天死亡率相关(p<0.001)。
  • 多因素分析显示肝硬化与90天死亡率独立相关(HR=1.56,95%CI 1.20-2.02)。
  • 合并与不合并肝硬化的ARDS患者死亡率随时间均无变化。
  • 非肝硬化ARDS患者SOFA评分(p=0.04)和非肝SOFA评分(p=0.02)随时间升高,肝硬化患者保持稳定。
  • 两组潮气量、呼气末正压、平台压及驱动压无差异。

证据类型、等级与局限

  • 证据类型:观察性队列研究(对前瞻性队列的回顾性分析)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,尽管过去几十年ARDS管理有所改善,合并肝硬化(57%)和不合并肝硬化(41%)的ARDS患者90天死亡率仍高且随时间保持稳定。
  • 作者认为,不合并肝硬化的患者严重程度随时间增加,而合并肝硬化的患者严重程度保持稳定。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: In studies prior to lung-protective ventilation, liver cirrhosis in acute respiratory distress syndrome (ARDS) was associated with high mortality rates. Since patients with cirrhosis have been excluded from many trials on ARDS, their outcome when treated with lung-protective ventilation is unclear. The objectives were to assess whether cirrhosis is associated with mortality in ARDS and trends over time in mortality and severity.

METHODS: We conducted a retrospective analysis of a prospective observational cohort conducted in a 20-bed tertiary ICU from October 2003 to December 2021. All consecutive adult critically ill patients with ARDS were included. ARDS was defined by the Berlin criteria. The primary outcome was 90 day mortality, assessed with Kaplan-Meier curves and multivariate Cox analysis. Time trends were assessed on 90 day mortality, Sequential Organ-Function Assessment score (SOFA) and non-hepatic SOFA. Ventilation settings were compared between patients with and without cirrhosis.

RESULTS: Of the 7155 patients screened, 863 had a diagnosis of ARDS. Among these ARDS patients, 157(18%) had cirrhosis. The overall 90 day mortality was of 43% (378/863), 57% (90/157) in patients with cirrhosis and 41% (288/706) in patients without cirrhosis (p < 0.001). On survival curves, cirrhosis was associated with 90 day mortality (p < 0.001). Cirrhosis was independently associated with 90 day mortality in multivariate analysis (hazard ratio = 1.56, 95% confidence interval 1.20-2.02). There was no change in mortality over time in ARDS patients with and without cirrhosis. SOFA (p = 0.04) and non-hepatic SOFA (p = 0.02) increased over time in ARDS patients without cirrhosis, and remained stable in ARDS patients with cirrhosis. Tidal volume, positive end-expiratory pressure, plateau pressure and driving pressure were not different between ARDS patients with and without cirrhosis.

CONCLUSIONS: Although ARDS management improved over the last decades, the 90 day mortality remained high and stable over time for both ARDS patients with (57%) and without cirrhosis (41%). Nevertheless, the severity of patients without cirrhosis has increased over time, while the severity of patients with cirrhosis has remained stable.

来源:Ann Intensive Care,查看原文。版权归原作者所有。

参考来源

  1. Pensier J, De Jong A, Monet C, et al. Outcomes and time trends of acute respiratory distress syndrome patients with and without liver cirrhosis: an observational cohort. Ann Intensive Care. 2023. PMID: 37773241. doi:10.1186/s13613-023-01190-1

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。